Top

Published in:

01-01-2010 | Review

Rhabdomyolysis: a review, with emphasis on the pediatric population

Authors: Essam F. Elsayed, Robert F. Reilly

Published in: Pediatric Nephrology | Issue 1/2010

Abstract

Rhabdomyolysis is a common clinical syndrome and accounts for 7% of all cases of acute kidney injury (AKI) in the USA. It can result from a wide variety of disorders, such as trauma, exercise, medications and infection, but in the pediatric population, infection and inherited disorders are the most common causes of rhabdomyolysis. Approximately half of patients with rhabdomyolysis present with the triad of myalgias, weakness and dark urine. The clinical suspicion, especially in the setting of trauma or drugs, is supported by elevated creatinine kinase levels and confirmed by the measurement of myoglobin levels in serum or urine. Muscle biopsy and genetic testing should be performed if rhabdomyolysis is recurrent or metabolic myopathy is suspected. Early recognition is important to prevent AKI through the use of aggressive hydration. Prevention is important in patients with inherited forms, but novel therapies may be developed with the better understanding of the pathophysiology and genetics of rhabdomyolysis.

Sauret JM, Marinides G, Wang GK (2002) Rhabdomyolysis. Am Fam Phys 65:907–912

Zager RA (1989) Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest 60:619–629PubMed

Fernandez WG, Hung O, Bruno GR, Galea S, Chiang WK (2005) Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med 23:1–7PubMed

Blanco JR, Zabalza M, Salcedo J, Echeverria L, Garcia A, Vallejo M (2002) Rhabdomyolysis of infectious and noninfectious causes. South Med J 95:542–544PubMed

Antons KA, Williams CD, Baker SK, Phillips PS (2006) Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 119:400–409PubMed

Gabow PA, Kaehny WD, Kelleher SP (1982) The spectrum of rhabdomyolysis. Medicine 61:141–152PubMed

Knochel JP (1982) Rhabdomyolysis and myoglobinuria. Annu Rev Med 33:435–443PubMed

Billis AG, Kastanakis S, Giamarellou H, Daikos GK (1971) Acute renal failure after a meal of quail. Lancet 2:702PubMed

Bywaters EG, Delory GE, Rimington C, Smiles J (1941) Myohaemoglobin in the urine of air raid casualties with crushing injury. Biochem J 35:1164–1168PubMedPubMedCentral

10.

Ward MM (1988) Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 148:1553–1557PubMed

11.

Mannix R, Tan ML, Wright R, Baskin M (2006) Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics 118:2119–2125

12.

Paletta CE, Lynch R, Knutsen AP (1993) Rhabdomyolysis and lower extremity compartment syndrome due to influenza B virus. Ann Plast Surg 30:272–273PubMed

13.

Gonzalez D (2005) Crush syndrome. Crit Care Med 33:S34–S41PubMed

14.

Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314–326PubMed

15.

Vanholder R, Sever MS, Erek E, Lameire N (2000) Rhabdomyolysis. J Am Soc Nephrol 11:1553–1561PubMed

16.

Menegaux JC (1962) Renal insufficiency in crush injuries of the muscles. Bywaters’ crush syndrome. J Chir 83:113–115

17.

Celik A, Ergun O, Ozok G (2004) Pediatric electrical injuries: a review of 38 consecutive patients. J Pediatr Surg 39:1233–1237PubMed

18.

Malinoski DJ, Slater MS, Mullins RJ (2004) Crush injury and rhabdomyolysis. Crit Care Clin 20:171–192PubMed

19.

Collins AJ (1989) Kidney dialysis treatment for victims of the Armenian earthquake. N Eng J Med 320:1291–1292

20.

Bocca G, van Moorselaar JA, Feitz WF, van der Staak FH, Monnens LA (2002) Compartment syndrome, rhabdomyolysis and risk of acute renal failure as complications of the lithotomy position. J Nephrol 15:183–185PubMed

21.

Mognol P, Vignes S, Chosidow D, Marmuse JP (2004) Rhabdomyolysis after laparoscopic bariatric surgery. Obes Surg 14:91–94PubMed

22.

Jolly BT, Talbot-Stern J (1995) Rhabdomyolysis secondary to keyboard overuse: occupational hazard of the computer age. Am J Emerg Med 13:644–646PubMed

23.

Tietjen DP, Guzzi LM (1989) Exertional rhabdomyolysis and acute renal failure following the Army Physical Fitness Test. Mil Med 154:23–25PubMed

24.

Kuipers H (1994) Exercise-induced muscle damage. Int J Sport Med 15:132–135

25.

Schiff HB, MacSearraigh ET, Kallmeyer JC (1978) Myoglobinuria, rhabdomyolysis and marathon running. Q J Med 47:463–472PubMed

26.

Kao PF, Tzen KY, Chen JY, Lin KJ, Tsai MF, Yen TC (1998) Rectus abdominis rhabdomyolysis after sit ups: unexpected detection by bone scan. Br J Sports Med 32:253–254PubMedPubMedCentral

27.

Nielsen C, Mazzone P (1999) Muscle pain after exercise. Lancet 353:1062PubMed

28.

Sultana SR, Byrne DJ (1996) ‘Raver’s’ haematuria. J R Coll Surg Edinb 41:419–420PubMed

29.

Spivak JL, Conti CR (1969) Post-seizure myoglobinuria. Johns Hopkins Med J 124:18–24PubMed

30.

Hue V, Martinot A, Fourier C, Cremer R, Leteurtre S, Leclerc F (1998) Acute rhabdomyolysis in the child. Arch Pediatr 5:887–895PubMed

31.

Hollander AS, Olney RC, Blackett PR, Marshall BA (2003) Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics 111:1447–1452PubMed

32.

Loke J, MacLennan DH (1998) Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am J Med 104:470–486PubMed

33.

Dell KM, Schulman SL (1997) Rhabdomyolysis and acute renal failure in a child with influenza A infection. Pediatr Nephrol 11:363–365

34.

Salcedo J, Blanco JR (1999) Acute rhabdomyolysis by Q fever. Enferm Infec Microbiol Clin 17:250–251

35.

Gamboa ET, Eastwood AB, Hays AP, Maxwell J, Penn AS (1979) Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 29:1323–1335PubMed

36.

Ruff RL, Secrist D (1982) Viral studies in benign acute childhood myositis. Arch Neurol 39:261–263PubMed

37.

Coco TJ, Klasner AE (2004) Drug-induced rhabdomyolysis. Curr Opin Pediatr 16:206–210PubMed

38.

Asberg A (2003) Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients. Drugs 63:367–378PubMed

39.

Schech S, Graham D, Staffa J, Andrade SE, La Grenade L, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D (2007) Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 16:352–358PubMed

40.

Goldman JA, Fishman AB, Lee JE, Johnson RJ (1989) The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheum 32:358–359PubMed

41.

Altman A, Szyper-Kravitz M, Shoenfeld Y (2007) Colchicine-induced rhabdomyolysis. Clin Rheumatol 26:2197–2199PubMed

42.

Seehusen DA, Asplund CA, Johnson DR, Horde KA (2006) Primary evaluation and management of statin therapy complications. South Med J 99:250–256PubMed

43.

Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R (2004) Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292:2585–2590PubMed

44.

Deighan CJ, Wong KM, McLaughlin KJ, Harden P (2000) Rhabdomyolysis and acute renal failure resulting from alcohol and drug abuse. QJM 93:29–33PubMed

45.

Singhal PC, Rubin RB, Peters A, Santiago A, Neugarten J (1990) Rhabdomyolysis and acute renal failure associated with cocaine abuse. J Toxicol Clin Toxicol 28:321–330PubMed

46.

Melli G, Chaudhry V, Cornblath DR (2005) Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine 84:377–385PubMed

47.

Miller F, Friedman R, Tanenbaum J, Griffin A (1991) Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome. J Clin Psychopharmacol 11:277–279PubMed

48.

Heled Y, Bloom MS, Wu TJ, Stephens Q, Deuster PA (2007) CK-MM and ACE genotypes and physiological prediction of the creatine kinase response to exercise. J Appl Physiol 103:504–510PubMed

49.

Rivera MA, Dionne FT, Wolfarth B, Chagnon M, Simoneau JA, Perusse L, Boulay MR, Gagnon J, Song TM, Keul J, Bouchard C (1997) Muscle-specific creatine kinase gene polymorphisms in elite endurance athletes and sedentary controls. Med Sci Sports Exerc 29:1444–1447PubMed

50.

Wang Y, Korman SH, Ye J, Gargus JJ, Gutman A, Taroni F, Garavaglia B, Longo N (2001) Phenotype and genotype variation in primary carnitine deficiency. Genet Med 3:387–392PubMed

51.

Kilfoyle D, Hutchinson D, Potter H, George P (2005) Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases. N Z Med J 118:U1320PubMed

52.

Deschauer M, Wieser T, Zierz S (2005) Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 62:37–41

53.

Longo N, di San A, Filippo C, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet 142C:77–85PubMed

54.

Kim JJ, Miura R (2004) Acyl-CoA dehydrogenases and acyl-CoA oxidases. Structural basis for mechanistic similarities and differences. Eur J Biochem 271:483–493PubMed

55.

Smelt AH, Poorthuis BJ, Onkenhout W, Scholte HR, Andresen BS, van Duinen SG, Gregersen N, Wintzen AR (1998) Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset. Ann Neurol 43:540–544PubMed

56.

Voermans NC, van Engelen BG, Kluijtmans LA, Stikkelbroeck NM, Hermus AR (2006) Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency. Am J Med 119:176–179PubMed

57.

Lucia A, Nogales-Gadea G, Perez M, Martin MA, Andreu AL, Arenas J (2008) McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol 4:568–577PubMed

58.

Burr ML, Roos JC, Ostor AJ (2008) Metabolic myopathies: a guide and update for clinicians. Curr Opin Rheumatol 20:639–647PubMed

59.

Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J, Malin JP (2000) Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 57:956–963PubMed

60.

Gross M, Rotzer E, Kolle P, Mortier W, Reichmann H, Goebel HH, Lochmuller H, Pongratz D, Mahnke-Zizelman DK, Sabina RL (2002) A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. Neuromuscul Disord 12:558–565PubMed

61.

Finsterer J, Stollberger C (2008) Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 24:786–792PubMedPubMedCentral

62.

Hoffman EP, Kunkel LM, Angelini C, Clarke A, Johnson M, Harris JB (1989) Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology 39:1011–1017PubMed

63.

De Keyser J, Smitz J, Malfait R, Ebinger G (1987) Rhabdomyolysis in hypokalaemic periodic paralysis: a clue to the mechanism that terminates the paralytic attack? J Neurol 234:119–121PubMed

64.

Bush SP, Jansen PW (1995) Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. Ann Emerg Med 25:845–848PubMed

65.

Olerud JE, Homer LD, Carroll HW (1976) Incidence of acute exertional rhabdomyolysis. Serum myoglobin and enzyme levels as indicators of muscle injury. Arch Intern Med 136:692–697PubMed

66.

Beetham R (2000) Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem 37:581–587PubMed

67.

Watanabe T (2001) Rhabdomyolysis and acute renal failure in children. Pediatr Nephrol 16:1072–1075PubMed

68.

Better OS, Stein JH (1990) Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Eng J Med 322:825–829

69.

McKenney JM, Davidson MH, Jacobson TA, Guyton JR (2006) Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 97:89C–94CPubMed

70.

Eneas JF, Schoenfeld PY, Humphreys MH (1979) The effect of infusion of mannitol-sodium bicarbonate on the clinical course of myoglobinuria. Arch Int Med 139:801–805

71.

Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC (2004) Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma 56:1191–1196PubMed

72.

Sharp LS, Rozycki GS, Feliciano DV (2004) Rhabdomyolysis and secondary renal failure in critically ill surgical patients. Am J Surg 188:801–806PubMed

73.

Schenk MR, Beck DH, Nolte M, Kox WJ (2001) Continuous veno-venous hemofiltration for the immediate management of massive rhabdomyolysis after fulminant malignant hyperthermia in a bodybuilder. Anesthesiology 94:1139–1141PubMed

74.

Cox GF, Souri M, Aoyama T, Rockenmacher S, Varvogli L, Rohr F, Hashimoto T, Korson MS (1998) Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 133:247–253PubMed

75.

Roe CR, Yang BZ, Brunengraber H, Roe DS, Wallace M, Garritson BK (2008) Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 71:260–264PubMedPubMedCentral

76.

Kiang A, Amalfitano A (2007) Progress and problems when considering gene therapy for GSD-II. Acta Myol 26:49–52PubMedPubMedCentral

Title: Rhabdomyolysis: a review, with emphasis on the pediatric population
Authors: Essam F. Elsayed
Robert F. Reilly
Publication date: 01-01-2010
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 1/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-009-1223-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rhabdomyolysis: a review, with emphasis on the pediatric population

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Multicenter study of effects of pediatric peritoneal dialysis practices on bacterial peritonitis

Outcomes of kidney transplant tourism in children: a single center experience

Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease

Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children

Severe atypical HUS caused by CFH S1191L—case presentation and review of treatment options

Biologically active ADAMTS13 is expressed in renal tubular epithelial cells